Not Disclosed
has been acquired by
June 2025
Medical Tech
Jason Arnold
Managing Director, Healthcare
About Jason
Jason Arnold is a managing director for William Blair based in the firm’s London office. He originally joined William Blair's investment banking team in 2009 and focuses his expertise on European diagnostics and tools. Before joining William Blair, he worked for Ernst & Young.
Awards and Affiliations
Certified Public Accountant (inactive)
Notable Transactions
Not Disclosed
has acquired a majority stake in
July 2024
Medical Tech
William Blair acted as the exclusive financial advisor to Novo Holdings in connection with its pending majority stake acquisition of Single Use Support.
Read more
Not Disclosed
has acquired
March 2024
Medical Tech
William Blair acted as the exclusive financial advisor to EQT in connection with its pending acquisition of Mabtech.
Read more
$379,730,000
Follow-on Offering
March 2024
Healthcare Services
$108,000,000
has been acquired by
October 2023
Medical Tech
William Blair acted as the exclusive financial advisor to PhenomeX Inc. (Nasdaq: CELL) in connection with its sale to Bruker Corporation (Nasdaq: BRKR).
Read more
€2,400,000,000
has acquired
July 2023
Medical Tech
William Blair acted as the exclusive financial advisor to Sartorius Group (XTRA:SRT) on its pending acquisition of Polyplus, for €2.4 billion, via its subsidiary Sartorius Stedim Biotech.
Read more
€160,000,000
has been acquired by
May 2023
Biopharma
Not Disclosed
has been acquired by
October 2022
Medical Tech
William Blair acted as the exclusive financial advisor to CEVEC Pharmaceuticals in connection with its sale to Danaher Corporation (NYSE: DHR) and its portfolio company Cytiva.
Read more
€135,000,000
has been acquired by
October 2022
Medical Tech
William Blair acted as the exclusive financial advisor to GenDx, a portfolio company of Ampersand Capital Partners, in connection with its pending sale to Eurobio Scientific (ENXTPA:ALERS) for €135 million in total consideration.
Read more
£415,000,000
has been acquired by
September 2022
Biopharma
€545,000,000
has been acquired by
September 2021
Medical Tech
William Blair acted as the exclusive financial advisor to HyTest, a portfolio company of Summa Equity in connection with its pending sale to Mindray (Shenzen Stock Exchange Ticker: 300760) for €545 million in total consideration.
Read more
$250,000,000
has been acquired by
May 2020
Medical Tech
Rigorous pursuit of your success. Every transaction. Every time.
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William Blair
Healthcare Services
William Blair’s Healthcare Services team is a trusted partner to providers, suppliers, and solutions providers across the healthcare continuum. Our knowledge of emerging healthcare trends and the nuances of reimbursement models have allowed us to help clients access capital and form valuable strategic partnerships.
More about our healthcare services expertise
About William Blair
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
-
1935Year William Blair was founded
-
2,000+Employees worldwide
-
145 billion+Client assets
-
90 YearsIndependent and employee-owned
-
20+Offices worldwide
-
650+Companies under coverage
As of June 30, 2025
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.